Preparing for Regulatory Review and Reimbursement DecisionsA Case for Cooperation between Regulatory Authorities, Sponsors and Health Technology Assessment Agencies

被引：0
|
作者：
Lawrence E. Liberti
Franz Pichler
Stuart R. Walker
机构：
[1] The Johnson Building,CMR International Institute for Regulatory Science
来源：
Pharmaceutical Medicine | 2009年 / 23卷 / 5-6期
关键词：
D O I：
10.1007/BF03256778
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：263 / 267
页数：4
相关论文
共 24 条
  • [1] Health Technology Assessment (HTA) evidence, regulatory classification and reimbursement of medicine: the case of glucosamine
    Luksameesate, Parnnaphat
    Taychakhoonavudh, Suthira
    [J]. JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2021, 12 (04) : 600 - 606
  • [2] The role of drug regulatory authorities and health technology assessment agencies in shaping incentives for antibiotic R&D: a qualitative study
    Kallberg, Cecilia
    Mathiesen, Liv
    Gopinathan, Unni
    Salvesen Blix, Hege
    [J]. JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2023, 16 (01)
  • [3] The role of drug regulatory authorities and health technology assessment agencies in shaping incentives for antibiotic R&D: a qualitative study
    Cecilia Kållberg
    Liv Mathiesen
    Unni Gopinathan
    Hege Salvesen Blix
    [J]. Journal of Pharmaceutical Policy and Practice, 16
  • [4] Green Technology and Assessment of the Environment and Challenges Faced by Regulatory Authorities in Uganda: A Case of the Electricity Regulatory Authority (ERA)
    Ariwa, Ezendu
    Katono, Isaac Wasswa
    [J]. GLOBAL TRENDS IN INFORMATION SYSTEMS AND SOFTWARE APPLICATIONS, PT 2, 2012, 270 : 780 - +
  • [5] Regulatory, health technology assessment and company interactions: the current landscape and future ecosystem for drug development, review and reimbursement
    Wang, Ting
    McAuslane, Neil
    Goettsch, Wim G.
    Leufkens, Hubert G. M.
    De Bruin, Marie L.
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2023, 39 (01)
  • [6] INTERNATIONAL COMPARISONS OF HEALTH TECHNOLOGY ASSESSMENT AND REIMBURSEMENT OUTCOMES FOR ONCOLOGY DRUGS WITH REGULATORY REVIEW THROUGH PROJECT ORBIS
    Beca, J.
    Scott, K.
    Gosselin, S.
    Ajrawat, P.
    Thon, J.
    Lee, S. M.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S238 - S238
  • [7] Modes of coordination for health technology adoption: Health Technology Assessment agencies and Group Procurement Organizations in a polycentric regulatory regime
    Miller, Fiona A.
    Lehoux, Pascale
    Rac, Valeria E.
    Bytautas, Jessica P.
    Krahn, Murray
    Peacock, Stuart
    [J]. SOCIAL SCIENCE & MEDICINE, 2020, 265
  • [8] A Comparison of Seven Oncology External Control Arm Case Studies: Critiques From Regulatory and Health Technology Assessment Agencies
    Jaksa, Ashley
    Louder, Anthony
    Maksymiuk, Christina
    Vondeling, Gerard T.
    Martin, Laura
    Gatto, Nicolle
    Richards, Eric
    Yver, Antoine
    Rosenlund, Mats
    [J]. VALUE IN HEALTH, 2022, 25 (12) : 1967 - 1976
  • [9] ALIGNING VALUE IN REGULATORY REVIEW, PRACTICE PATHWAYS, AND HEALTH TECHNOLOGY ASSESSMENT
    Garrison, L.
    Towse, A.
    [J]. VALUE IN HEALTH, 2019, 22 : S164 - S164
  • [10] Improving Interactions Between Health Technology Assessment Bodies and Regulatory Agencies: A Systematic Review and Cross-Sectional Survey on Processes, Progress, Outcomes, and Challenges
    Ofori-Asenso, Richard
    Hallgreen, Christine E.
    De Bruin, Marie Louise
    [J]. FRONTIERS IN MEDICINE, 2020, 7
123